{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T14:24:29Z","timestamp":1749133469231},"reference-count":24,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transfusion and Apheresis Science"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1016\/j.transci.2011.01.017","type":"journal-article","created":{"date-parts":[[2011,3,13]],"date-time":"2011-03-13T08:36:45Z","timestamp":1300005405000},"page":"211-221","source":"Crossref","is-referenced-by-count":5,"title":["Atypical myeloproliferative disorders in adults"],"prefix":"10.1016","volume":"44","author":[{"given":"Pierre","family":"Zach\u00e9e","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transci.2011.01.017_b0005","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/sj.leu.2404955","article-title":"Classification and diagnosis of myeloproliferative neoplasms: the 2008 World Health Organization criteria and point-of-care diagnostic algorithms","volume":"22","author":"Tefferi","year":"2008","journal-title":"Leukemia"},{"issue":"6","key":"10.1016\/j.transci.2011.01.017_b0010","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.jaci.2006.02.042","article-title":"Approaches to the treatment of hypereosinophilia syndromes: a workshop summary report","volume":"117","author":"Klion","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.transci.2011.01.017_b0015","series-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","author":"Swerdlow","year":"2008"},{"key":"10.1016\/j.transci.2011.01.017_b0020","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1046\/j.1365-2141.2002.03234.x","article-title":"Chronic neutrophilic leukaemia; a distinct clinical entity?","volume":"116","author":"Reilly","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1016\/j.transci.2011.01.017_b0025","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1136\/jcp.55.11.862","article-title":"Chronic neutrophilic leukaemia: 14 new cases of an uncommon myeloproliferative disease","volume":"55","author":"B\u00f6hm","year":"2002","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.transci.2011.01.017_b0030","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/j.jaci.2009.09.022","article-title":"Hypereosinophilic syndrome: a multicenter, retrospective analysis of clinical characteristics and response to therapy","volume":"124","author":"Ogbogu","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.transci.2011.01.017_b0035","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1056\/NEJM198406213102501","article-title":"Episodic angioedema associated with eosinophilia","volume":"310","author":"Gleich","year":"1984","journal-title":"N Engl J Med"},{"key":"10.1016\/j.transci.2011.01.017_b0040","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1146\/annurev.med.60.062107.090340","article-title":"Hypereosinophilic syndrome: current approach to diagnosis and treatment","volume":"60","author":"Klion","year":"2009","journal-title":"Ann Rev Med"},{"key":"10.1016\/j.transci.2011.01.017_b0045","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1046\/j.1365-2141.1996.00298.x","article-title":"Further evidence for the clonal nature of the idiopathic hypereosinophilic syndrome: complete haematological and cytogenetic remission induced by interferon-alpha in a case with a unique chromosomal abnormality","volume":"92","author":"Malbrain","year":"1996","journal-title":"Br J Haematol"},{"key":"10.1016\/j.transci.2011.01.017_b0050","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1056\/NEJMoa070812","article-title":"Treatment of patients with the hypereosinophilic syndrome with mepolizumab","volume":"358","author":"Rothenberg","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.transci.2011.01.017_b0055","doi-asserted-by":"crossref","first-page":"553","DOI":"10.4065\/81.4.553","article-title":"Atypical myeloproliferative disorders: diagnosis and management","volume":"81","author":"Tefferi","year":"2006","journal-title":"Mayo Clin Proc"},{"issue":"4","key":"10.1016\/j.transci.2011.01.017_b0060","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/sj.leu.2403313","article-title":"Clinical and molecular features of FIP1L1\u2013PDFGRA (+) chronic eosinophilic leukemias","volume":"18","author":"Vandenberghe","year":"2004","journal-title":"Leukemia"},{"key":"10.1016\/j.transci.2011.01.017_b0065","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1056\/NEJMoa025217","article-title":"A tyrosine kinase created by fusion of the PDGFRA and FIP-1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome","volume":"348","author":"Cools","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.transci.2011.01.017_b0070","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jaci.2004.02.045","article-title":"Diagnosis and classification of mast cell proliferative disorders: delineation from immunologic diseases and non-mast cell hematopoietic neoplasms","volume":"114","author":"Valent","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.transci.2011.01.017_b0075","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1146\/annurev.med.55.091902.103822","article-title":"Systemic mastocytosis","volume":"55","author":"Akin","year":"2004","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.transci.2011.01.017_b0080","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1365-2362.2007.01807.x","article-title":"Standards and standardization in mastocytosis: concensus statements on diagnosis, treatment recommendations and response criteria","volume":"37","author":"Valent","year":"2007","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.transci.2011.01.017_b0085","unstructured":"Horny HP, Metcalfe DD, Bennett JM, Bain BJ. Mastocytosis. In: Swerdlow SH, Campo E, Harris NL, et al., editors, WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon, France: IARC Press; 2008. p54."},{"key":"10.1016\/j.transci.2011.01.017_b0090","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1182\/blood-2007-11-078097","article-title":"Mast cells and mastocytosis","volume":"112","author":"Metcalfe","year":"2008","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.transci.2011.01.017_b0095","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3816\/CLK.2006.n.014","article-title":"Myelodysplastic\/myeloproliferative disorder overlap syndrome: how should it be approached?","volume":"1","author":"Litzrow","year":"2006","journal-title":"Clin Leukemia"},{"key":"10.1016\/j.transci.2011.01.017_b0100","unstructured":"Orazi A, Bennett JM, Germing U, et al. Chronic myelomonocytic leukemia. In: Swerdlow SH, Campo E, Harris NL, et al., editors, WHO classification of tumours of haemaetopoietic and lymphoid tissues. Lyon, France: IARC Press; 2008. p76."},{"key":"10.1016\/j.transci.2011.01.017_b0105","unstructured":"Vardiman JW, Bennett JM, Bain BJ, et al. Atypical chronic myelocytic leukemia, BCR-ABL1. In: Swerdlow SH, Campo E, Harris NL, et al., editors, WHO classification of tumours of haemaetopoietic and lymphoid tissues. Lyon, France: IARC Press; 2008. p80."},{"key":"10.1016\/j.transci.2011.01.017_b0110","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1034\/j.1600-0609.2003.00086.x","article-title":"Chronic basophilic leukemia: a distinct clinico-pathologic entity?","volume":"71","author":"Pardanani","year":"2003","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.transci.2011.01.017_b0115","unstructured":"Kvasnicka HM, et al. In: Swerdlow SH, et al., editors, WHO classification of tumours of haemaetopoietic and lymphoid tissues. Lyon, France: IARC Press; 2008. p31."},{"key":"10.1016\/j.transci.2011.01.017_b0120","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1182\/blood-2006-03-008227","article-title":"The JAK-2-V617F mutation and essential thrombocythemia features in a subset of patients with refractory anemia and ring sideroblasts","volume":"108","author":"Boissinot","year":"2006","journal-title":"Blood"}],"container-title":["Transfusion and Apheresis Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050211000334?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050211000334?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,4]],"date-time":"2018-12-04T01:51:55Z","timestamp":1543888315000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1473050211000334"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["S1473050211000334"],"URL":"https:\/\/doi.org\/10.1016\/j.transci.2011.01.017","relation":{},"ISSN":["1473-0502"],"issn-type":[{"value":"1473-0502","type":"print"}],"subject":[],"published":{"date-parts":[[2011,4]]}}}